NMO SPECTRUM DISORDER
Clinical trials for NMO SPECTRUM DISORDER explained in plain language.
Never miss a new study
Get alerted when new NMO SPECTRUM DISORDER trials appear
Sign up with your email to follow new studies for NMO SPECTRUM DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New registry study tests antibody drugs for rare nerve disease
Disease control Recruiting nowThis study tracks 200 adults with a specific type of neuromyelitis optica (NMO), a rare disease that attacks the nerves in the eyes and spine. Researchers are monitoring how well different antibody-based medicines work in real-world settings, focusing on preventing relapses and c…
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC
-
Could zapping the brain ease nerve pain for NMOSD patients?
Symptom relief Recruiting nowThis study is testing a non-invasive brain stimulation technique called tTIS to see if it can safely reduce nerve pain in people with neuromyelitis optica spectrum disorder (NMOSD). The trial will enroll 12 adults who have had nerve pain for at least 3 months. Researchers will me…
Matched conditions: NMO SPECTRUM DISORDER
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated Jun 15, 2026 19:02 UTC
-
Massive brain imaging study aims to unlock secrets of nerve inflammation
Knowledge-focused Recruiting nowThis study is observing 1,000 people with neuroinflammatory diseases like multiple sclerosis and neuromyelitis optica. Researchers use advanced MRI and PET scans to track changes in the brain, spinal cord, and optic nerve over one year. The goal is to better understand how these …
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: Beijing Tiantan Hospital • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC
-
AI set to revolutionize multiple sclerosis diagnosis and monitoring
Knowledge-focused Recruiting nowThis study collects health data from 7,000 people with multiple sclerosis (MS) and related conditions to build artificial intelligence (AI) models. The goal is to help doctors better diagnose, predict disease course, and monitor treatment response in real-world settings. No new t…
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: icometrix • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:18 UTC